Posts Tagged ‘NICE’
UK cost body finally approves limited use of GSK’s lupus drug
Britain’s healthcare cost watchdog has finally approved GlaxoSmithKline’s lupus drug Benlysta for limited use, after rejecting it since 2011 on the grounds that it failed to offer good value for money.
Read More